Compare SUN & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SUN | ASND |
|---|---|---|
| Founded | 1960 | 2006 |
| Country | United States | Denmark |
| Employees | N/A | N/A |
| Industry | Integrated oil Companies | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.2B | 14.7B |
| IPO Year | 2012 | 2014 |
| Metric | SUN | ASND |
|---|---|---|
| Price | $68.34 | $221.85 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 16 |
| Target Price | $68.33 | ★ $281.50 |
| AVG Volume (30 Days) | 301.4K | ★ 751.0K |
| Earning Date | 05-05-2026 | 05-12-2026 |
| Dividend Yield | ★ 5.45% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | ★ $25,201,000,000.00 | N/A |
| Revenue This Year | $63.67 | $96.35 |
| Revenue Next Year | $0.84 | $44.91 |
| P/E Ratio | $26.93 | ★ N/A |
| Revenue Growth | ★ 11.05 | N/A |
| 52 Week Low | $47.98 | $151.11 |
| 52 Week High | $69.53 | $250.74 |
| Indicator | SUN | ASND |
|---|---|---|
| Relative Strength Index (RSI) | 61.39 | 43.01 |
| Support Level | $62.43 | $214.92 |
| Resistance Level | N/A | $233.88 |
| Average True Range (ATR) | 1.41 | 7.56 |
| MACD | 0.39 | -2.06 |
| Stochastic Oscillator | 80.57 | 16.98 |
Sunoco LP is engaged in the distribution of motor fuels to independent dealers, distributors, and other commercial customers as well as the distribution of motor fuels to end-use customers at retail sites operated by commission agents. It is a growth-oriented master limited partnership (MLP) that operates as a wholesale and retail fuel distributor in the United States. The firm operates through the Fuel Distribution; Pipeline Systems; Refinery and Terminals segments. It generates the majority of its revenue from the Fuel Distribution segment. It distributes motor fuel to convenience stores, dealers, and commercial customers in various states.
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.